The Employees' State Insurance Corporation (ESIC), on May 07, 2026, released the list of drugs and pharmaceutical items sent for quality testing for the month of April 2026 from ESIC medical institutions. The samples include medicines procured under ESIC rate contracts, CPSE supplies, and Jan Aushadhi schemes. [List dated May 07, 2026]
The testing list covers various formulations including Spironolactone, Ibuprofen + Paracetamol, Clonazepam, Metronidazole, Furosemide, Pregabalin, Amoxycillin + Clavulanic Acid, Clotrimazole, Tranexamic Acid, Bisacodyl, Mannitol, Levofloxacin, Gentamicin, Mupirocin, Cetirizine, and Montelukast + Levocetirizine. The drug samples were sourced from manufacturers such as Hindustan Antibiotics Limited, Biodeal Pharmaceuticals Limited, Micron Pharmaceuticals, Bengal Chemicals and Pharmaceuticals Ltd and Karnataka Antibiotics and Pharmaceuticals Ltd. [List dated May 07, 2026]
The samples were sent to testing laboratories including ITL Labs Pvt. Ltd, and the status of all reports is presently marked as “Awaiting”. The testing exercise forms part of ESIC’s ongoing drug quality surveillance and procurement monitoring mechanism.
